Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (171-180 of 244) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|July 11, 2017
CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in BotswanaRobert Gross, Scarlett L Bellamy, Bakgaki Ratshaa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2006
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patientsVincent Lo Re, Ian Frank, Robert Gross, et al.
Neurology|October 30, 2021
Association Between Anatomical Location of Surgically Induced Lesions and Postoperative Seizure Outcome in Temporal Lobe EpilepsyEzequiel Gleichgerrcht, Daniel L Drane, Simon S Keller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2013
Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 studyIra B Wilson, David R Bangsberg, Jie Shen, et al.
Archives of Internal Medicine|July 15, 2009
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trialRobert Gross, Camlin Tierney, Adriana Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trialsJean B Nachega, Jean-Jacques Parienti, Olalekan A Uthman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2022
Brief Report: HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living With HIVYotam Arens, Warren B Bilker, Xiaoyan Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
Drug and Alcohol Dependence Reports|July 21, 2025
A formative study to develop nudges informed by behavioral economics to increase engagement with tobacco treatment among people who smoke receiving care for HIVDaniel Blumenthal, Nathaniel Stevens, Frank T Leone, et al.
Drug and Alcohol Dependence|April 1, 2020
Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trialRobert Schnoll, E Paul Wileyto, Robert Gross, et al.
Pageof 25

Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|July 11, 2017
CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in BotswanaRobert Gross, Scarlett L Bellamy, Bakgaki Ratshaa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2006
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patientsVincent Lo Re, Ian Frank, Robert Gross, et al.
Neurology|October 30, 2021
Association Between Anatomical Location of Surgically Induced Lesions and Postoperative Seizure Outcome in Temporal Lobe EpilepsyEzequiel Gleichgerrcht, Daniel L Drane, Simon S Keller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2013
Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 studyIra B Wilson, David R Bangsberg, Jie Shen, et al.
Archives of Internal Medicine|July 15, 2009
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trialRobert Gross, Camlin Tierney, Adriana Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trialsJean B Nachega, Jean-Jacques Parienti, Olalekan A Uthman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2022
Brief Report: HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living With HIVYotam Arens, Warren B Bilker, Xiaoyan Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
Drug and Alcohol Dependence Reports|July 21, 2025
A formative study to develop nudges informed by behavioral economics to increase engagement with tobacco treatment among people who smoke receiving care for HIVDaniel Blumenthal, Nathaniel Stevens, Frank T Leone, et al.
Drug and Alcohol Dependence|April 1, 2020
Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trialRobert Schnoll, E Paul Wileyto, Robert Gross, et al.
Pageof 25